PETS Stock Overview
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
PetMed Express, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.97 |
| 52 Week High | US$22.64 |
| 52 Week Low | US$10.48 |
| Beta | 0.68 |
| 1 Month Change | -2.66% |
| 3 Month Change | -21.31% |
| 1 Year Change | -43.60% |
| 3 Year Change | -64.54% |
| 5 Year Change | -66.77% |
| Change since IPO | 777.60% |
Recent News & Updates
Recent updates
PetMed Express (NASDAQ:PETS) Is Paying Out A Dividend Of $0.30
Aug 07
The Returns On Capital At PetMed Express (NASDAQ:PETS) Don't Inspire Confidence
Mar 23PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30
Feb 10PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30
Nov 11PetMed Express Puts Are Compelling
Aug 25PetMed Express CFO to leave post today, by remain with company over transition period
Aug 02PetMed Express' (NASDAQ:PETS) Dividend Will Be $0.30
Jul 29PetMed Express FQ1 2023 Earnings Preview
Jul 24PetMeds becomes exclusive U.S. fulfillment partner for Vetster, telemedicine platform
Jul 15Returns On Capital At PetMed Express (NASDAQ:PETS) Paint A Concerning Picture
Jul 04PetMed Express: 'AutoShip & Save' Program Key Driver Of Growth
May 26PetMed Express (NASDAQ:PETS) Has Affirmed Its Dividend Of US$0.30
May 13Silver Ring Value Partners - PetMed Express: Squeezed Out Of Obtaining New Customers
Feb 22PetMed Express: Avoid For Now
Jan 17PetMed Express Needs A White Knight
Sep 26PetMed Express (NASDAQ:PETS) Is Increasing Its Dividend To US$0.30
Jul 29PetMed Express: Top Dog For Pet Dividends - Pet Industry Review
Jul 11PetMed Express: A Safe Dividend, But Lacks A Margin Of Safety
Jun 15Estimating The Intrinsic Value Of PetMed Express, Inc. (NASDAQ:PETS)
Jun 11PetMed reaches highest level since January as meme stocks rally
Jun 02PetMed Express EPS misses by $0.06, misses on revenue
May 03PetMed Express Q4 2021 Earnings Preview
Apr 30Is PetMed Express, Inc. (NASDAQ:PETS) An Attractive Dividend Stock?
Mar 24Estimating The Intrinsic Value Of PetMed Express, Inc. (NASDAQ:PETS)
Mar 09Does PetMed Express' (NASDAQ:PETS) Statutory Profit Adequately Reflect Its Underlying Profit?
Feb 22Has PetMed Express (NASDAQ:PETS) Got What It Takes To Become A Multi-Bagger?
Feb 10
Don't Ignore The Fact That This Insider Just Sold Some Shares In PetMed Express, Inc. (NASDAQ:PETS)
Jan 29Just Four Days Till PetMed Express, Inc. (NASDAQ:PETS) Will Be Trading Ex-Dividend
Jan 24Shareholder Returns
| PETS | US Specialty Retail | US Market | |
|---|---|---|---|
| 7D | -6.4% | -4.2% | -3.1% |
| 1Y | -43.6% | 10.3% | 15.1% |
Return vs Industry: PETS underperformed the US Specialty Retail industry which returned 10.3% over the past year.
Return vs Market: PETS underperformed the US Market which returned 15.1% over the past year.
Price Volatility
| PETS volatility | |
|---|---|
| PETS Average Weekly Movement | 4.7% |
| Specialty Retail Industry Average Movement | 6.5% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in US Market | 14.2% |
| 10% least volatile stocks in US Market | 2.5% |
Stable Share Price: PETS is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: PETS's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 302 | Matt Hulett | https://www.1800petmeds.com |
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
PetMed Express, Inc. Fundamentals Summary
| PETS fundamental statistics | |
|---|---|
| Market Cap | US$223.04m |
| Earnings (TTM) | -US$3.43m |
| Revenue (TTM) | US$264.92m |
0.8x
P/S Ratio-65.0x
P/E RatioIs PETS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PETS income statement (TTM) | |
|---|---|
| Revenue | US$264.92m |
| Cost of Revenue | US$191.32m |
| Gross Profit | US$73.60m |
| Other Expenses | US$77.03m |
| Earnings | -US$3.43m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.17 |
| Gross Margin | 27.78% |
| Net Profit Margin | -1.29% |
| Debt/Equity Ratio | 0% |
How did PETS perform over the long term?
See historical performance and comparison